Life Sciences Innovation and Investment: An AWS Executive Leadership Reception

​AWS Life Sciences Executive Discussion New York City

​Where Pharma, Capital, and AI-Native Startups Meet

​Following the AWS Life Sciences Symposium, join an invitation-only reception with the senior leaders shaping the future of life sciences — from drug discovery and clinical development to the AI-driven platforms redefining how therapeutics reach patients.

​This dialogue brings together pharmaceutical executives, life sciences investors, and venture-backed founders to explore the forces driving long-term industry growth: how capital is being deployed, where external innovation strategies are heading, and what the rise of AI-native approaches means for the next era of biotech.

​What to Expect

• ​A moderated executive conversation led by AWS

• ​A senior pharmaceutical leader anchoring the industry perspective

• ​Leading life sciences VC sharing the capital view

• ​Two select startups representing AI-native and biotech innovation models

• ​Hors d'oeuvres and premium cocktails from our friends at Avra

• ​A candid, off-the-record dialogue — not a pitch session

​Panelists

​Shaq Vayda, Partner at Lux Captial

​Dan Neil, CTO at Formation Bio

​Sarah Nam, VP of AI Strategies and Partnerships at AbbVie

​Justin Johnson, Executive Director, Oncology Data at AstraZeneca

​In Partnership With

​Loka
An AWS Innovation Partner of the Year (2024), Loka builds compliant AI, data, and cloud platforms for life sciences — helping biopharma teams move from prototype to production faster.

​DuploCloud
A DevOps automation platform purpose-built for regulated industries, enabling life sciences organizations to scale securely and compliantly on AWS.